← Organizations
Sponsor / Institution
House Research Institute
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
2
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
2
0 open data checks
Company / Institution Links
0 / 2
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
15
Completion Signal
50
Programs by Stage
Phase 1/21
Phase 31
Trial / Program Status
Discontinued2
Modality Mix
Biologic1
Small Molecule1
Indication Coverage
Hearing Loss2
Autoimmune Inner Ear Disease1
Sensorineural Hearing Loss1
Program Types
Therapeutic2
Population Tags
adult2
autoimmune-inner-ear-disease1
meniere-disease1
sensorineural-hearing-loss1
steroid-dependent1
unilateral1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
2 checked · 0 open checksHouse Research Institute Famciclovir Study in Unilateral Meniere's Disease
Details checked
Small MoleculePhase 3Discontinued
Terminated Phase 3 randomized placebo-controlled study of oral famciclovir/Famvir for hearing fluctuation in unilateral Meniere's disease.
Data checks: industry-collaborated-study, registry-only-evidence
Intratympanic golimumab for autoimmune inner ear disease
Details checked
BiologicPhase 1/2Discontinued
TNF-alpha inhibitor delivered by intratympanic injection for autoimmune inner ear disease with progressive bilateral sensorineural hearing loss.
Data checks: institution-led-study, industry-collaborator-not-primary-sponsor